Translationale Infektionsmedizin

Deinhardt-Emmer S, Chousterman BG, Schefold JC, Flohé SB, Skirecki T, Kox M, Winkler MS, Cossarizza A, Wiersinga WJ, van der Poll T, Weigand MA, Cajander S, Giamarellos-Bourboulis EJ, Lachmann G, Girardis M, Scicluna BP, Ferrer R, Payen D, Weis S, Torres A, Bermejo-Martín JF, Osuchowski MF, Rubio I, Bouma HR (2025) Sepsis in patients who are immunocompromised: diagnostic challenges and future therapies. Lancet Respir Med 13(7), 623-637. (Review)

Gheitasi R, Baumgart S, Roell D, Rose N, Watzl C, Dudziak D, Andreas N, Makarewicz O, Drube S, Schnizer C, Kamradt T, Weis S, Pletz MW (2025) Age- and sex-associated differences in immune cell populations. iScience 28(8), 113092.

Schellong P, Joean O, Pletz MW, Hagel S, Weis S (2025) Treatment of complicated gram-positive bacteremia and infective endocarditis. Drugs 85(2), 193-214. (Review)

van Hout D, Mouncey P, Harrison D, Bonten M, Derde L, Angus DC, Anjum A, Annane D, Best-Lane J, Brunkhorst F, Cecconi M, Ehrmann S, Gordon A, Hays LM, Kester E, Mahon N, McArthur C, Nichol A, Peters S, Pugliese S, Rowan K, Torre-Cisneros J, Weis S (2025) Hurdles for the delivery of multinational randomized clinical trials. JAMA Netw Open 8(7), e2518503.

Westfall S, Gentile ME, Olsen TM, Karo-Atar D, Bogza A, Röstel F, Pardy RD, Mandato G, Fontes G, Herbert D, Melichar HJ, Abadie V, Richer MJ, Vinh DC, Koenig JFE, Harrison OJ, Divangahi M, Weis S, Gregorieff A, King IL (2025) A type 1 immune-stromal cell network mediates disease tolerance against intestinal infection. Cell 188(12), 3135-3151.e22.

Xu LL, Zhou Z, Schäuble S, Vivas W, Dlubatz K, Bauer M, Weis S, Singer M, Lukaszewski R, Panagiotou G^# (2025) Multi-omics and -organ insights into energy metabolic adaptations in early sepsis onset. Advanced Science [Epub ahead of print]

Bahrs C, Schönherr C, Panning M, Rose N, Dähne T, Hagel S, Weis S, Rupp J, Rohde G, Witzenrath M, Pletz MW (2024) Frequency and clinical significance of Herpes simplex virus type 1/2 reactivation in adult patients with mild to moderately severe community-acquired pneumonia: a multicentre cohort study. Infection 53(1), 449-455.

Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, Kyriazopoulou E, Lupse M, Monneret G, Pickkers P, Schultze JL, van der Poll T, van de Veerdonk FL, Vlaar APJ, Weis S, Wiersinga WJ, Netea MG (2024) The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol 25(1), 19-28. (Review)

Kaasch AJ, López-Cortés LE, Rodríguez-Baño J, Cisneros JM, Dolores Navarro M, Fätkenheuer G, Jung N, Rieg S, Lepeule R, Coutte L, Bernard L, Lemaignen A, Kösters K, MacKenzie CR, Soriano A, Hagel S, Fantin B, Lafaurie M, Talarmin JP, Dinh A, Guimard T, Boutoille D, Welte T, Reuter S, Kluytmans J, Martin ML, Forestier E, Stocker H, Vitrat V, Tattevin P, Rommerskirchen A, Noret M, Adams A, Kern WV, Hellmich M, Seifert H (2024) Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial. Lancet Infect Dis 24(5), 523-534.